Moreover, LILRB4 has been found on TAMs in several cancer types, and its blocking enhances the infiltration of anti-tumour immune cells due to the increased secretion of IL-1β and inducible nitric oxide synthase (184). This evidence concerns the gene LILRB4 and cancer.